Louis S. Harris

Virginia Commonwealth University School of Medicine, Richmond, VA 
Pharmacology, opioid, pain, analgesics
"Louis Harris"
Mean distance: 16.45 (cluster 32)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Walentiny D, Harris L. (2015) Characterization of morphine discriminative stimulus properties in C57BL/6 mice Drug and Alcohol Dependence. 146: e15
Ben Haddou T, Malfacini D, Calo G, et al. (2014) Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor. Molecular Pain. 10: 48
Moynihan HA, Derrick I, Broadbear JH, et al. (2012) Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effects. Journal of Medicinal Chemistry. 55: 9868-74
Wise LE, Premaratne ID, Gamage TF, et al. (2012) l-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like activity in mice. Pharmacology, Biochemistry, and Behavior. 103: 245-52
Follia V, Aceto MD, Harris LS, et al. (2011) Introduction of a 6-cyano group in 14-oxygenated N-methylmorphinans influences in vitro and in vivo pharmacological activities Bmc Pharmacology. 11: A26
Kwilasz AJ, Harris LS, Vann RE. (2009) Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice. Pharmacology, Biochemistry, and Behavior. 94: 114-8
Cami-Kobeci G, Neal AP, Bradbury FA, et al. (2009) Mixed kappa/mu opioid receptor agonists: the 6 beta-naltrexamines. Journal of Medicinal Chemistry. 52: 1546-52
Metcalf MD, Aceto MD, Harris LS, et al. (2008) The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans. Bioorganic & Medicinal Chemistry. 16: 869-73
Hiebel AC, Lee YS, Bilsky E, et al. (2007) Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series. Journal of Medicinal Chemistry. 50: 3765-76
Naidu PS, Lichtman AH, Archer CC, et al. (2007) NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action. European Journal of Pharmacology. 566: 132-6
See more...